Fact CheckerSign in

NCT03027856Completed

The BIFSORB Pilot Study II

A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions - The BIFSORB Pilot Study II

Source: ClinicalTrials.gov · Last updated 2 Jan 2026

Brief summary (registry, in English)

The purpose of this study is to investigate the feasibility and safety of the Magmaris BRS for treatment of coronary bifurcation lesions.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (estimated)
First submitted
22 Nov 2016
Start date
Sept 2016
Primary completion date
Aug 2019
Lead sponsor
Aarhus University Hospital Skejby
NCT number
NCT03027856

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From Sept 2016 to the primary completion date, Aug 2019
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe heart failure (NYHA≥III)
  • Allergy to contrast media, aspirin, clopidogrel, ticagrelor, ticlopidine or sirolimus

Lab values

  • S-creatinine \> 120 µmol/L or GFR \< 0.45 mL/min per 1.73 m2

Other

  • ST-elevation infarction within 48 hours
  • Expected survival \< 1 year
  • Unable to cover main vessel lesion with one stent
  • Severe tortuosity
  • Severe calcification

Who the study is looking for

  • Stable angina pectoris
  • Stabilized non-ST elevation myocardial infarction
  • Silent angina pectoris
  • Age \> 18 years
  • De novo coronary bifurcation lesion at LAD/diagonal, CX/obtuse marginal or RCA-PDA/posterolateral branch
  • All Medina classes except Medina x.x.1.
  • Diameter of side branch ≥ 2.5 mm
  • Side branch diameter stenosis less than 50%
  • Signed informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aarhus University Hospital
Coordinator of this site? Confirm its status
Aarhus NDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.